Carapenem resistance in India remains alarmingly high, primarily driven by NDM and OXA‐type carbapenemases, and optimised diagnostics, improved access to effective antimicrobials, robust antimicrobial stewardship, and national surveillance are critical to mitigate its growing clinical and public health impact.
A. Kapoor, Anuj Gupta, Bipinesh Sansar et al.· BioMed Research Internationa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.